AB

Arcus Biosciences

RCUS

NYSEHealth Care

Income Statement

Total Revenue$258M

Gross Profit$258M

Operating Income$-330M

EBITDA$-261M

EBIT$-278M

Pre-tax Income$-353M

Net Income$-283M

Balance Sheet

Cash Equivalent$173M

Total Debt$23.75M

Book Value$598M

Book Value Per Share6.56

Key Ratios

Return on Equity (ROE)-58.35%

Return on Assets (ROA)-24.61%

Return on Invested Capital (ROI)-53.10%

Net Profit Margin-109.69%

Current Ratio4.50

Quick Ratio4.44

Long-Term Debt / Equity0.10